Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
ASEAN+3 Summit: PM Chính called for cooperation in supply chains, new growth drivers, climate resilience 5.